Renal Disease Research Institute

WHAT HAPPENS WHEN YOU VOLUNTEER? Thinking about joining our study? Here's what to expect: 1. The RDRI research team will talk to you about the study. You will be asked to sign a consent and will be given a copy. The consent form explains why the study is being done and what the study involves (including the chance of receiving a placebo). A placebo is a pill that does not contain active medicine. The consent form also explains possible side effects and how data collected about you will be used. 2. If you agree to join the study, a screening visit occurs. At the screening visit, the research team collects your medical history, and lab tests are performed. The information collected will determine if you can join the study. 3. If you join the study, the RDRI research doctor will begin closely monitoring your health. You will attend study visits at the clinic for physical exams and lab tests. You will also be asked to report side effects or changes to your health. 4. You will continue to see your own doctor for your routine healthcare. At your request, test results will be shared with your doctor.

WHY VOLUNTEER FOR A CLINICAL TRIAL? Joining a study is a way to help others and possibly yourself by contributing to new scientific research. Research studies are very important for the development of new medications and devices to treat chronic kidney diseases.

WHAT IS A CLINICAL TRIAL? A clinical trial is also called a research study. During a research study, patients are asked if they would like to join a study to test a new treatment.

Did you know that you can quickly search for a clinical trial by? • Condition or disease (for example, breast cancer or high blood pressure) • Other terms (for example, a treatment, NCT number, or investigator name) • Intervention/Treatment (for example, radiation therapy or low fat diet) • Location (search by address, city, state, or country) Visit https://lnkd.in/eJsJN5J to start your search. ClinicalTrials.gov is a place to learn about clinical studies from around the world.

🚨 Exciting Opportunity! 🚨 We're testing a new oral medication for chronic kidney disease (CKD) and need participants! 💊 Take either the study medication or a placebo daily for 3 months. 🔍 Continue your current CKD meds or get an FDA-approved option provided by the study. 🗓️ Total study duration: 4.5 months, including 9 office visits. 👩⚕️ Expect physical exams, lab tests, and ECGs. Join us to advance CKD treatment! https://lnkd.in/dP26XMCD 💡 #CKDResearch #ClinicalTrial #MedicalBreakthrough

🌟 On Friday, July 5th we celebrated Research Awareness Day! 🌟 At the Renal Disease Research Institute, we're dedicated to pushing the boundaries of science to find innovative solutions for renal disease. Every breakthrough starts with research, and every discovery brings us one step closer to a world without renal disease. Join us in honoring the brilliant minds and tireless efforts of our researchers who work relentlessly to improve the lives of millions. Your support fuels our passion and drives us forward. Together, we can make a difference. Together, we can give hope. 💪🧬💙 #ResearchAwarenessDay #RenalDiseaseResearch #InnovateForLife #HopeThroughScience #RenalDiseaseAwareness #SupportResearch

In observance of the 4th of July, Renal Disease Research Institute will be closed. We will resume normal business hours on July 5th. We hope everyone enjoys this special day with family and friends, celebrating the freedom and independence that make our country great. Stay safe, have fun, and enjoy the fireworks! Happy Independence Day from all of us at RDRI!

🌟 Join Our Clinical Trial and Make a Difference! 🌟 The Renal Disease Research Institute is seeking participants for an exciting clinical trial aimed at combating serious heart-related complications and preventing the worsening of kidney function. This is your chance to contribute to groundbreaking research and help improve lives! Study Details: 🔹 Purpose: To determine if Retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. 🔹 Who Can Join: Adults with a body mass index of 27 kg/m² or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. 🔹 Duration: The study will last about 5 years. 🔹 Visits: Participants will have up to 27 clinic visits with the study doctor. Be a part of something big! Your participation could lead to advancements in treatment and offer hope to millions affected by cardiovascular and kidney diseases. 👉 Sign up today! Visit our website for more information and to see if you qualify: https://lnkd.in/dP26XMCD #ClinicalTrial #RenalResearch #HeartHealth #KidneyHealth #JoinUs #MedicalResearch #HealthMatters

ClinicalTrials.gov is a website and online database of clinical research studies and information about their results. It is a place where you can learn about clinical studies from around the world. The purpose of ClinicalTrials.gov is to provide information about clinical research studies to the public, researchers, and healthcare professionals. https://lnkd.in/ev3X6Hp

Renal Disease Research Institute (RDRI) offers people the opportunity to participate in clinical research by managing scientifically feasible and ethical clinical trials. Clinical research studies are necessary to prove that a medicine or treatment is both safe and effective. Our clinical trials improve our future ability to treat kidney disease and give our patients the opportunity to receive cutting-edge therapy. At RDRI, there is significant ethical oversight of this entity through RDRI’s Board of Managers and Scientific Review Committee. Choosing to participate in a study is an important personal decision. Are you interested in participating in a study? Talk with your doctor and family members or friends about deciding to join a study. For a list of RDRI’s current research studies, visit https://lnkd.in/dP26XMCD.